Published in Transplantation on November 27, 2003
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood (2011) 5.82
Exosome function: from tumor immunology to pathogen biology. Traffic (2008) 4.50
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Exosomes: immune properties and potential clinical implementations. Semin Immunopathol (2010) 2.60
Tetraspanins in extracellular vesicle formation and function. Front Immunol (2014) 1.56
The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J (2007) 1.50
Role of exosomes in immune regulation. J Cell Mol Med (2006) 1.29
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med (2008) 1.28
Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev (2013) 1.25
Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol (2014) 1.19
Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model. PLoS One (2012) 1.15
Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol (2012) 1.09
Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant (2007) 1.06
Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice. Infect Immun (2006) 1.01
The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy (2015) 1.00
Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology (2007) 0.98
Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages. PLoS One (2011) 0.98
Immunotherapeutic potential of extracellular vesicles. Front Immunol (2014) 0.94
MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. Haematologica (2012) 0.93
B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. Eur J Immunol (2009) 0.93
Immature dendritic cell-derived exosomes: a promise subcellular vaccine for autoimmunity. Inflammation (2013) 0.91
Administration of the stress protein gp96 prolongs rat cardiac allograft survival, modifies rejection-associated inflammatory events, and induces a state of peripheral T-cell hyporesponsiveness. Cell Stress Chaperones (2007) 0.90
Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. Front Immunol (2014) 0.88
Exosomes: an overview of biogenesis, composition and role in ovarian cancer. J Ovarian Res (2014) 0.88
Immune regulation by non-lymphoid cells in transplantation. Clin Exp Immunol (2009) 0.84
Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol (2016) 0.83
Stem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics. Stem Cells Int (2016) 0.83
Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System. Ocul Surf (2016) 0.81
Extracellular vesicles in cardiovascular disease: are they Jedi or Sith? J Physiol (2016) 0.80
Transplant tolerance: new insights and strategies for long-term allograft acceptance. Clin Dev Immunol (2013) 0.80
Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools. Front Cell Neurosci (2016) 0.80
Combining Exosomes Derived from Immature DCs with Donor Antigen-Specific Treg Cells Induces Tolerance in a Rat Liver Allograft Model. Sci Rep (2016) 0.77
Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. Cent Eur J Immunol (2014) 0.77
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma. Oncotarget (2016) 0.76
Extracellular Vesicles from MSC Modulate the Immune Response to Renal Allografts in a MHC Disparate Rat Model. Stem Cells Int (2015) 0.75
The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression. Tumour Biol (2016) 0.75
LIMLE, a new molecule over-expressed following activation, is involved in the stimulatory properties of dendritic cells. PLoS One (2014) 0.75
Phenotyping of Leukocytes and Leukocyte-Derived Extracellular Vesicles. J Immunol Res (2016) 0.75
Extracellular vesicles in renal disease. Nat Rev Nephrol (2017) 0.75
Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45
Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol (2008) 1.95
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood (2007) 1.91
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood (2005) 1.86
Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int (2007) 1.65
Characterization of immunoglobulin heavy chain knockout rats. Eur J Immunol (2010) 1.63
Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol (2010) 1.51
Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats. Gastroenterology (2010) 1.48
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol (2007) 1.46
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation (2005) 1.41
CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest (2007) 1.23
Zinc-finger nucleases: a powerful tool for genetic engineering of animals. Transgenic Res (2009) 1.22
Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun (2004) 1.22
Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int (2005) 1.13
Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J Leukoc Biol (2013) 1.13
Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant (2005) 1.12
CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network. Neoplasia (2013) 1.11
Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol (2008) 1.11
Transgenic modifications of the rat genome. Transgenic Res (2005) 1.08
Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol (2010) 1.05
Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol (2002) 1.04
Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation (2011) 1.02
Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant (2005) 1.02
Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J (2012) 1.00
Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J Immunol (2002) 1.00
Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest (2002) 0.98
Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J Immunol (2008) 0.96
Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant (2005) 0.93
Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol (2007) 0.92
Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5. J Immunol (2012) 0.92
Superiority of bone marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque. Transplantation (2008) 0.90
Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. J Immunol (2005) 0.90
Analysis by quantitative PCR of zygosity in genetically modified organisms. Methods Mol Biol (2010) 0.89
The effect of a first kidney transplant on a subsequent transplant outcome: an experimental and clinical study. Kidney Int (2005) 0.87
Preparation of mouse bone marrow-derived dendritic cells with immunoregulatory properties. Methods Mol Biol (2011) 0.85
Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease. Parkinsons Dis (2011) 0.85
Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney Int (2010) 0.85
TNF blockade abrogates the induction of T cell-dependent humoral responses in an allotransplantation model. J Leukoc Biol (2011) 0.85
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation (2005) 0.85
IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest (2015) 0.84
Depletion of LAG-3 positive cells in cardiac allograft reveals their role in rejection and tolerance. Transplantation (2007) 0.84
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. J Immunol (2004) 0.84
Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets. J Immunol (2006) 0.83
Modulation of regulatory T cell-Th17 balance by plasmacytoid dendritic cells. J Leukoc Biol (2011) 0.82
Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T-cell differentiation. Am J Transplant (2002) 0.82
Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats. Transplantation (2007) 0.81
Long term transgene expression by hepatocytes transduced with retroviral vectors requires induction of immune tolerance to the transgene. J Hepatol (2004) 0.81
The use of lentiviral vectors to obtain transgenic rats. Methods Mol Biol (2010) 0.80
Dominant tolerance to kidney allografts induced by anti-donor MHC class II antibodies: cooperation between T and non-T CD103+ cells. J Immunol (2006) 0.79
Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation. Transplantation (2012) 0.78
Development of initial idiopathic nephrotic syndrome and post-transplantation recurrence: evidence of the same biological entity. Nephrol Dial Transplant (2010) 0.77
Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4. PLoS One (2011) 0.77
Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas. Int Immunol (2011) 0.77
What is the role of antigen-processing mechanisms in autologous tolerogenic dendritic cell therapy in organ transplantation? Immunotherapy (2011) 0.77
Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival. Transplantation (2004) 0.76
"Transgenesis, recent technical developments and applications" Nantes, 8th June 2009. Transgenic Res (2009) 0.75
Exhaustive depletion of graft resident dendritic cells: marginally delayed rejection but strong alteration of graft infiltration. Transplantation (2005) 0.75
Technical advances in the generation of transgenic animals and in their applications. Nantes, France, June 7th 2013. Transgenic Res (2013) 0.75
Autoimmune responses against renal tissue proteins in long-term surviving allograft recipients. Transpl Int (2009) 0.75
Generation of transgenic rats by microinjection of short DNA fragments. Methods Mol Biol (2010) 0.75